Показано 0 из 0
Дата |
---|
30.05.2024 |
29.05.2024 |
28.05.2024 |
27.05.2024 |
24.05.2024 |
23.05.2024 |
22.05.2024 |
21.05.2024 |
20.05.2024 |
17.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
4 735.00
|
4 695.00
|
4 800.00
|
4 725.00
|
|
|
48 190 530.00
|
|
|
|
4 740.00
|
4 695.00
|
4 810.00
|
4 735.00
|
|
|
102 237 945.00
|
|
|
|
4 715.00
|
4 690.00
|
4 740.00
|
4 730.00
|
|
|
85 792 535.00
|
|
|
|
4 715.00
|
4 680.00
|
4 730.00
|
4 715.00
|
|
|
46 478 440.00
|
|
|
|
4 755.00
|
4 680.00
|
4 830.00
|
4 715.00
|
|
|
60 617 930.00
|
|
|
|
4 800.00
|
4 710.00
|
4 800.00
|
4 750.00
|
|
|
50 058 090.00
|
|
|
|
4 770.00
|
4 740.00
|
4 800.00
|
4 785.00
|
|
|
26 073 800.00
|
|
|
|
4 830.00
|
4 750.00
|
4 900.00
|
4 790.00
|
|
|
96 518 505.00
|
|
|
|
4 830.00
|
4 805.00
|
4 870.00
|
4 845.00
|
|
|
123 538 050.00
|
|
|
|
4 800.00
|
4 700.00
|
4 855.00
|
4 845.00
|
|
|
149 236 580.00
|
|
Psomagen, Inc. established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.